Market Cap 8.55B
Revenue (ttm) 2.57B
Net Income (ttm) -1.84B
EPS (ttm) N/A
PE Ratio 31.74
Forward PE 32.66
Profit Margin -71.86%
Debt to Equity Ratio 0.18
Volume 107,200
Avg Vol 225,602
Day's Range N/A - N/A
Shares Out 26.98M
Stochastic %K 42%
Beta 1.04
Analysts Sell
Price Target $341.25

Company Profile

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, q...

Industry: Medical Devices
Sector: Healthcare
Phone: 510 724 7000
Fax: 510 741 5817
Address:
1000 Alfred Nobel Drive, Hercules, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:34 AM
$BIO: The last close at $313.15 indicates a position near the middle of the 60-day range (high of $343.12 and low of $266.71). The RSI of 38.07 suggests that the stock is nearing oversold conditions, which may indicate a potential reversal or bounce. The MA30 at $314.74 is slightly above the current price, while the MA50 at $302.14 is below, indicating mixed short-term momentum. Directional bias leans towards a potential bullish reversal given the low RSI and proximity to the 60D low. Suggested entry is at $315.00, slightly above the last close to confirm upward movement. Set a stop loss at $302.00, just below the MA50 for risk management. Target 1 is $325.00, aligning with previous resistance levels, and Target 2 is $335.00, near the 60D high. Monitor market conditions closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:07 AM
$BIO Market Context: The last close of $316.89 indicates the stock is currently positioned above its 30-day moving average (MA30) of $314.48 but below its 60-day high of $343.12. The RSI at 38.12 suggests the stock is nearing oversold territory, indicating potential for upward movement. Directional Bias: The combination of a low RSI and proximity to the MA30 suggests a potential bullish reversal. However, the stock is still below its MA50 of $301.78, indicating caution. The recent high-low range shows a significant volatility span (60D High of $343.12 and Low of $266.71), allowing for potential price movement. Suggested Entry: Consider entering at $318, slightly above the last close to confirm upward momentum. Stop: Set a stop at $310 to limit potential losses. Targets: Aim for a first target at $330, near the previous resistance, and a second target at $340, approaching the recent high. https://privateprofiteers.com
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 13 at 3:21 PM
$BIO Share Price: $325.39 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $12.75 – $15.75 Target Zone: $20.46 – $25.00 Potential Upside: 52% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:14 AM
$BIO: The current market context shows a last close of $313.33, with an RSI of 36.7 indicating that the stock is nearing oversold territory, which may suggest a potential reversal or bounce. The 30-day moving average (MA30) at $312.75 is slightly above the last close, providing a resistance level, while the 50-day moving average (MA50) at $300.45 indicates a longer-term bullish trend, as it is significantly lower than the current price. The 60-day high of $343.12 and low of $266.71 suggest a wide trading range, allowing for volatility. Directional bias leans towards a potential upward movement given the low RSI and proximity to MA30. Suggested entry is at $312.75 (MA30), with a stop loss at $300 (MA50). Target 1 is $330 (mid-range of recent highs), and Target 2 is $340 (near the 60D high). https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:50 AM
$BIO: The current market context shows a last close of $313.33, with an RSI of 36.7 indicating that the stock is nearing oversold territory, which may suggest a potential reversal or bounce. The 30-day moving average (MA30) at $312.75 is slightly above the last close, providing a resistance level, while the 50-day moving average (MA50) at $300.45 indicates a longer-term bullish trend, as it is significantly lower than the current price. The 60-day high of $343.12 and low of $266.71 suggest a wide trading range, allowing for volatility. Directional bias leans towards a potential upward movement given the low RSI and proximity to MA30. Suggested entry is at $312.75 (MA30), with a stop loss at $300 (MA50). Target 1 is $330 (mid-range of recent highs), and Target 2 is $340 (near the 60D high). https://privateprofiteers.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 9:29 PM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 5 at 3:09 AM
$BIO Share Price: $311.51 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $8.50 – $10.50 Target Zone: $15.04 – $18.38 Potential Upside: 67% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 4 at 9:17 PM
0 · Reply
MKRReformed
MKRReformed Oct. 21 at 4:46 PM
$ADVB great intraday move so far bro $BIO $NERV $VSEE
1 · Reply
SpartanVI
SpartanVI Oct. 21 at 2:57 PM
$ADVB $NERV $VSEE $BIO Advb had that look
0 · Reply
Latest News on BIO
Bio-Rad Reports Third-Quarter 2025 Financial Results

Oct 29, 2025, 4:15 PM EDT - 16 days ago

Bio-Rad Reports Third-Quarter 2025 Financial Results


7 Stocks Taking The Next Step To Be On Offense

Oct 23, 2025, 7:30 PM EDT - 22 days ago

7 Stocks Taking The Next Step To Be On Offense

ACI CNX FCF FDX FIS IAC KHC


Bio-Rad Reports Second-Quarter 2025 Financial Results

Jul 31, 2025, 4:15 PM EDT - 3 months ago

Bio-Rad Reports Second-Quarter 2025 Financial Results


Bio-Rad Reports First-Quarter 2025 Financial Results

May 1, 2025, 4:15 PM EDT - 7 months ago

Bio-Rad Reports First-Quarter 2025 Financial Results


Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript

Feb 13, 2025, 11:45 PM EST - 9 months ago

Bio-Rad Laboratories, Inc. (BIO) Q4 2024 Earnings Call Transcript


Bio-Rad Reports Third-Quarter 2024 Financial Results

Oct 30, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Third-Quarter 2024 Financial Results


Bio-Rad Reports Second-Quarter 2024 Financial Results

Aug 1, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports Second-Quarter 2024 Financial Results


Bio-Rad Reports First-Quarter 2024 Financial Results

May 7, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad Reports First-Quarter 2024 Financial Results


Bio-Rad Announces Life Science Group Management Changes

Apr 26, 2024, 8:30 AM EDT - 1 year ago

Bio-Rad Announces Life Science Group Management Changes


Bio-Rad's Chief Operating Officer Andrew Last to Retire

Apr 10, 2024, 4:15 PM EDT - 1 year ago

Bio-Rad's Chief Operating Officer Andrew Last to Retire


PrivateProfiteer
PrivateProfiteer Nov. 15 at 12:34 AM
$BIO: The last close at $313.15 indicates a position near the middle of the 60-day range (high of $343.12 and low of $266.71). The RSI of 38.07 suggests that the stock is nearing oversold conditions, which may indicate a potential reversal or bounce. The MA30 at $314.74 is slightly above the current price, while the MA50 at $302.14 is below, indicating mixed short-term momentum. Directional bias leans towards a potential bullish reversal given the low RSI and proximity to the 60D low. Suggested entry is at $315.00, slightly above the last close to confirm upward movement. Set a stop loss at $302.00, just below the MA50 for risk management. Target 1 is $325.00, aligning with previous resistance levels, and Target 2 is $335.00, near the 60D high. Monitor market conditions closely for any changes in momentum. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 4:07 AM
$BIO Market Context: The last close of $316.89 indicates the stock is currently positioned above its 30-day moving average (MA30) of $314.48 but below its 60-day high of $343.12. The RSI at 38.12 suggests the stock is nearing oversold territory, indicating potential for upward movement. Directional Bias: The combination of a low RSI and proximity to the MA30 suggests a potential bullish reversal. However, the stock is still below its MA50 of $301.78, indicating caution. The recent high-low range shows a significant volatility span (60D High of $343.12 and Low of $266.71), allowing for potential price movement. Suggested Entry: Consider entering at $318, slightly above the last close to confirm upward momentum. Stop: Set a stop at $310 to limit potential losses. Targets: Aim for a first target at $330, near the previous resistance, and a second target at $340, approaching the recent high. https://privateprofiteers.com
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 13 at 3:21 PM
$BIO Share Price: $325.39 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $12.75 – $15.75 Target Zone: $20.46 – $25.00 Potential Upside: 52% ROI Time to Expiration: 216 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 2:14 AM
$BIO: The current market context shows a last close of $313.33, with an RSI of 36.7 indicating that the stock is nearing oversold territory, which may suggest a potential reversal or bounce. The 30-day moving average (MA30) at $312.75 is slightly above the last close, providing a resistance level, while the 50-day moving average (MA50) at $300.45 indicates a longer-term bullish trend, as it is significantly lower than the current price. The 60-day high of $343.12 and low of $266.71 suggest a wide trading range, allowing for volatility. Directional bias leans towards a potential upward movement given the low RSI and proximity to MA30. Suggested entry is at $312.75 (MA30), with a stop loss at $300 (MA50). Target 1 is $330 (mid-range of recent highs), and Target 2 is $340 (near the 60D high). https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:50 AM
$BIO: The current market context shows a last close of $313.33, with an RSI of 36.7 indicating that the stock is nearing oversold territory, which may suggest a potential reversal or bounce. The 30-day moving average (MA30) at $312.75 is slightly above the last close, providing a resistance level, while the 50-day moving average (MA50) at $300.45 indicates a longer-term bullish trend, as it is significantly lower than the current price. The 60-day high of $343.12 and low of $266.71 suggest a wide trading range, allowing for volatility. Directional bias leans towards a potential upward movement given the low RSI and proximity to MA30. Suggested entry is at $312.75 (MA30), with a stop loss at $300 (MA50). Target 1 is $330 (mid-range of recent highs), and Target 2 is $340 (near the 60D high). https://privateprofiteers.com
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 9 at 9:29 PM
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 5 at 3:09 AM
$BIO Share Price: $311.51 Contract Selected: Jun 18, 2026 $370 Calls Buy Zone: $8.50 – $10.50 Target Zone: $15.04 – $18.38 Potential Upside: 67% ROI Time to Expiration: 225 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 4 at 9:17 PM
0 · Reply
MKRReformed
MKRReformed Oct. 21 at 4:46 PM
$ADVB great intraday move so far bro $BIO $NERV $VSEE
1 · Reply
SpartanVI
SpartanVI Oct. 21 at 2:57 PM
$ADVB $NERV $VSEE $BIO Advb had that look
0 · Reply
Paraboljoker
Paraboljoker Oct. 21 at 2:56 PM
$ADVB $.48 strong setup bio play bottom here IPO $4.X low float, bio's exploding of $NERV $VSEE $BIO
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 7:27 PM
Enter: $BIO NOV 21 2025 $320 CALLS Buy in Price: $9.75 - $15.00 Take Profit: $15.31 Stop Bleeding: $8.58 ROI Potential: 57% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Wigglyick
Wigglyick Oct. 16 at 8:38 PM
That sound you hear is the sucking chest wound in my acct…. But……some things working but not enough to matter, lol. $VEEV $BWXT $ANET $BIO had a good day, though I don’t own it yet
0 · Reply
Wigglyick
Wigglyick Oct. 16 at 1:46 PM
$BIO highlighted BioRad 10 days ago, breaking out. ER coming up end of month. Good luck
0 · Reply
Invest2live
Invest2live Oct. 15 at 8:20 PM
$GNPX 247% already; congrats 🎈 🎊🎉 Check out $BIO Check out $IBIO and $ rxrx
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 7:26 PM
RBC Capital has updated their rating for Bio-Rad Laboratories ( $BIO ) to Outperform with a price target of 447.
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 7:24 PM
RBC Capital has adjusted their stance on Bio-Rad Laboratories ( $BIO ), setting the rating to Outperform with a target price of 430 → 409.
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 7:22 PM
Citigroup updates rating for Bio-Rad Laboratories ( $BIO ) to Buy, target set at 450 → 400.
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 4:52 PM
Results of list 9/26/25 $BIIB $BIO $BIPC $BIRK 🔥 Cycle Trading Signal plugged into AI 🔥 list 🔥
0 · Reply
Wigglyick
Wigglyick Oct. 5 at 9:20 PM
$BIO BioRad looks like it’s trying to get back to the 370-400 range. Just had a gold cross on the daily and a MACD cross.
0 · Reply